Fig. 3: Prognostication with tumor budding in the complete EC cohort.
From: Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups

Kaplan–Meier curves of overall (a) and recurrence-free survival (b) across the complete cohort of EMCAs without further subtyping with p values derived from log-rank tests.